ABOS: Acumen Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ABOS: Acumen Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 59.36
Enterprise Value ($M) 53.15
Book Value ($M) 181.82
Book Value / Share 3.00
Price / Book 0.33
NCAV ($M) 121.13
NCAV / Share 2.00
Price / NCAV 0.49

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.39

Liquidity (mrq)
Quick Ratio 6.45
Current Ratio 6.46

Balance Sheet (mrq) ($M)
Current Assets 178.31
Assets 238.99
Liabilities 57.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -114.02
Net Income -102.33

Cash Flow Statement (mra) ($M)
Cash From Operations -86.22
Cash from Investing 48.03
Cash from Financing 6.93

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-31 13D/A Ra Capital Management, L.p. 24.80 0.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 159,852 464,587 34.41
2025-04-16 71,627 164,202 43.62
2025-04-15 69,315 167,973 41.27
2025-04-14 51,275 147,889 34.67

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABUS – Arbutus Biopharma Corporation
ACAD – ACADIA Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io